K. Abe, A. Nozaki, K. Tamura, M. Ikeda, K. Naka et al., Tandem Repeats of Lactoferrin-Derived Anti-Hepatitis C Virus Peptide Enhance Antiviral Activity in Cultured Human Hepatocytes, Microbiology and Immunology, vol.71, issue.1, pp.117-125, 2007.
DOI : 10.1111/j.1348-0421.2007.tb03882.x

S. L. Acton, P. E. Scherer, H. F. Lodish, and M. Krieger, Expression cloning of SR- BI, a CD36-related class B scavenger receptor, J Biol Chem, issue.33, pp.269-21003, 1994.

V. Agnello, G. Abel, M. Elfahal, G. B. Knight, and Q. X. Zhang, Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor, Proceedings of the National Academy of Sciences, vol.96, issue.22, pp.96-12766, 1999.
DOI : 10.1073/pnas.96.22.12766

M. Ait-goughoulte, C. Hourioux, R. Patient, S. Trassard, D. Brand et al., Core protein cleavage by signal peptide peptidase is required for hepatitis C virus-like particle assembly, Journal of General Virology, vol.87, issue.4, pp.855-860, 2006.
DOI : 10.1099/vir.0.81664-0
URL : https://hal.archives-ouvertes.fr/inserm-00128751

H. Aizaki, K. J. Lee, V. M. Sung, H. Ishiko, and M. M. Lai, Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts, Virology, vol.324, issue.2, pp.450-461, 2004.
DOI : 10.1016/j.virol.2004.03.034

H. Aizaki, S. Nagamori, M. Matsuda, H. Kawakami, O. Hashimoto et al., Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor, Virology, vol.314, issue.1, pp.314-330, 2003.
DOI : 10.1016/S0042-6822(03)00383-0

D. Akazawa, T. Date, K. Morikawa, A. Murayama, M. Miyamoto et al., CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection, Journal of Virology, vol.81, issue.10, pp.81-5036, 2007.
DOI : 10.1128/JVI.01573-06

L. Alexopoulou, A. C. Holt, R. Medzhitov, and R. A. Flavell, Recognition of doublestranded RNA and activation of NF-kappaB by Toll-like receptor 3, Nature, issue.6857, pp.413-732, 2001.

S. Ali, V. Leveque, L. Pogam, S. Ma, H. Philipp et al., Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479, Antimicrobial Agents and Chemotherapy, vol.52, issue.12, pp.52-4356, 2008.
DOI : 10.1128/AAC.00444-08

P. Andre, F. Komurian-pradel, S. Deforges, M. Perret, J. L. Berland et al., Characterization of low-and very-low-density hepatitis C virus RNAcontaining particles, J Virol, issue.14, pp.76-6919, 2002.

P. Andre, G. Perlemuter, A. Budkowska, C. Brechot, and V. Lotteau, Hepatitis C Virus Particles and Lipoprotein Metabolism, Seminars in Liver Disease, vol.25, issue.01, pp.93-104, 2005.
DOI : 10.1055/s-2005-864785

Y. Aoki, H. Aizaki, T. Shimoike, H. Tani, K. Ishii et al., A Human Liver Cell Line Exhibits Efficient Translation of HCV RNAs Produced by a Recombinant Adenovirus Expressing T7 RNA Polymerase, Virology, vol.250, issue.1, pp.140-150, 1998.
DOI : 10.1006/viro.1998.9361

Y. Ariumi, M. Kuroki, H. Dansako, K. Abe, M. Ikeda et al., The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication, J Virol, issue.19, pp.82-9639, 2008.

R. Bartenschlager, The hepatitis C virus replicon system: From basic research to clinical application, Journal of Hepatology, vol.43, issue.2, pp.210-216, 2005.
DOI : 10.1016/j.jhep.2005.05.013

R. Bartenschlager, L. Ahlborn-laake, J. Mous, and H. Jacobsen, Kinetic and structural analyses of hepatitis C virus polyprotein processing, J Virol, issue.8, pp.68-5045, 1994.

R. Bartenschlager and V. Lohmann, Replication of hepatitis C virus, Journal of General Virology, vol.81, issue.7, pp.1631-1648, 2000.
DOI : 10.1099/0022-1317-81-7-1631
URL : https://hal.archives-ouvertes.fr/hal-00313684

R. Bartenschlager and S. Sparacio, Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture, Virus Research, vol.127, issue.2, pp.195-207, 2007.
DOI : 10.1016/j.virusres.2007.02.022

H. Barth, E. K. Schnober, F. Zhang, R. J. Linhardt, E. Depla et al., Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction, J Virol, issue.21, pp.80-10579, 2006.

H. Barth, A. Ulsenheimer, G. R. Pape, H. M. Diepolder, M. Hoffmann et al., Uptake and presentation of hepatitis C virus-like particles by human dendritic cells, Blood, vol.105, issue.9, pp.3605-3614, 2005.
DOI : 10.1182/blood-2004-05-1952

B. Bartosch, J. Dubuisson, and F. L. Cosset, Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1???E2 Envelope Protein Complexes, The Journal of Experimental Medicine, vol.72, issue.5, pp.633-642, 2003.
DOI : 10.1093/emboj/21.12.2893
URL : https://hal.archives-ouvertes.fr/inserm-00133783

L. Bassit, J. Grier, M. Bennett, and R. F. Schinazi, -Methylcytidine Analogues with Interferon-??2b and Triple Combination with Ribavirin in the Hepatitis C Virus Replicon System, Antiviral Chemistry and Chemotherapy, vol.36, issue.8, pp.25-31, 2008.
DOI : 10.1128/JVI.77.10.5933-5947.2003
URL : https://hal.archives-ouvertes.fr/tel-00555543

T. F. Baumert, S. Ito, D. T. Wong, and T. J. Liang, Hepatitis C virus structural proteins assemble into viruslike particles in insect cells, J Virol, issue.5, pp.72-3827, 1998.

T. F. Baumert, J. Vergalla, J. Satoi, M. Thomson, M. Lechmann et al., Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate, Gastroenterology, vol.117, issue.6, pp.117-1397, 1999.
DOI : 10.1016/S0016-5085(99)70290-8

P. L. Beaulieu, Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections, Curr Opin Investig Drugs, vol.8, issue.8, pp.614-634, 2007.

I. Benedicto, F. Molina-jimenez, O. Barreiro, A. Maldonado-rodriguez, J. Prieto et al., Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum, Hepatology, vol.82, issue.7-8, pp.1044-1053, 2008.
DOI : 10.1002/hep.22465

R. Bhindi, R. G. Fahmy, H. C. Lowe, C. N. Chesterman, C. R. Dass et al., Brothers in Arms, The American Journal of Pathology, vol.171, issue.4, pp.1079-1088, 2007.
DOI : 10.2353/ajpath.2007.070120

T. Bian, Y. Zhou, S. Bi, W. Tan, and Y. Wang, HCV envelope protein function is dependent on the peptides preceding the glycoproteins, Biochemical and Biophysical Research Communications, vol.378, issue.1, pp.118-122, 2009.
DOI : 10.1016/j.bbrc.2008.11.024

E. Blanchard, S. Belouzard, L. Goueslain, T. Wakita, J. Dubuisson et al., Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis, Journal of Virology, vol.80, issue.14, pp.80-6964, 2006.
DOI : 10.1128/JVI.00024-06
URL : https://hal.archives-ouvertes.fr/hal-00105504

E. Blanchard, D. Brand, and P. Roingeard, Endogenous Virus and Hepatitis C Virus-Like Particle Budding in BHK-21 Cells, Journal of Virology, vol.77, issue.6, pp.3888-3889, 2003.
DOI : 10.1128/JVI.77.6.3888-3889.2003

E. Blanchard, D. Brand, S. Trassard, A. Goudeau, and P. Roingeard, Hepatitis C Virus-Like Particle Morphogenesis, Journal of Virology, vol.76, issue.8, pp.76-4073, 2002.
DOI : 10.1128/JVI.76.8.4073-4079.2002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC136094

E. Blanchard, C. Hourioux, D. Brand, M. Ait-goughoulte, A. Moreau et al., Hepatitis C Virus-Like Particle Budding: Role of the Core Protein and Importance of Its Asp111, Journal of Virology, vol.77, issue.18, pp.77-10131, 2003.
DOI : 10.1128/JVI.77.18.10131-10138.2003

K. J. Blight, A. A. Kolykhalov, and C. M. Rice, Efficient Initiation of HCV RNA Replication in Cell Culture, Science, vol.290, issue.5498, pp.290-1972, 2000.
DOI : 10.1126/science.290.5498.1972

J. G. Bode, E. D. Brenndorfer, and D. Haussinger, Subversion of innate host antiviral strategies by the hepatitis C virus, Archives of Biochemistry and Biophysics, vol.462, issue.2, pp.254-265, 2007.
DOI : 10.1016/j.abb.2007.03.033

S. Boni, J. P. Lavergne, S. Boulant, and A. Cahour, Hepatitis C Virus Core Protein Acts as a trans-Modulating Factor on Internal Translation Initiation of the Viral RNA, Journal of Biological Chemistry, vol.280, issue.18, pp.28017737-28017785, 2005.
DOI : 10.1074/jbc.M501826200
URL : https://hal.archives-ouvertes.fr/hal-00314209

I. Boo, A. E. Fischer, D. Johnson, R. Chin, M. Giourouki et al., Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin, Journal of Clinical Virology, vol.39, issue.4, pp.288-294, 2007.
DOI : 10.1016/j.jcv.2007.04.019

N. Branza-nichita, D. Durantel, S. Carrouee-durantel, R. A. Dwek, and N. Zitzmann, Antiviral Effect of N-Butyldeoxynojirimycin against Bovine Viral Diarrhea Virus Correlates with Misfolding of E2 Envelope Proteins and Impairment of Their Association into E1-E2 Heterodimers, Journal of Virology, vol.75, issue.8, pp.75-3527, 2001.
DOI : 10.1128/JVI.75.8.3527-3536.2001

M. Brazzoli, A. Bianchi, S. Filippini, A. Weiner, Q. Zhu et al., CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes, Journal of Virology, vol.82, issue.17, pp.82-8316, 2008.
DOI : 10.1128/JVI.00665-08

V. M. Breinholt, E. A. Offord, C. Brouwer, S. E. Nielsen, K. Brosen et al., In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids, Food and Chemical Toxicology, vol.40, issue.5, pp.40-609, 2002.
DOI : 10.1016/S0278-6915(01)00125-9

S. Brill, C. Zimmermann, K. Berger, J. Drewe, and H. Gutmann, In vitro Interactions with Repeated Grapefruit Juice Administration -to Peel or not to Peel, 2009.

M. Buck, Direct Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte Cultures, PLoS ONE, vol.276, issue.2, p.2660, 2008.
DOI : 10.1371/journal.pone.0002660.s004

A. Budhu, Y. Chen, J. W. Kim, M. Forgues, K. Valerie et al., Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins, Carcinogenesis, vol.28, issue.7, pp.28-1552, 2007.
DOI : 10.1093/carcin/bgm075

Z. Cai, L. Cai, J. Jiang, K. S. Chang, D. R. Van-der-westhuyzen et al., Human Serum Amyloid A Protein Inhibits Hepatitis C Virus Entry into Cells, Journal of Virology, vol.81, issue.11, pp.81-6128, 2007.
DOI : 10.1128/JVI.02627-06

Z. Cai, C. Zhang, K. S. Chang, J. Jiang, B. C. Ahn et al., Robust Production of Infectious Hepatitis C Virus (HCV) from Stably HCV cDNA-Transfected Human Hepatoma Cells, Journal of Virology, vol.79, issue.22, pp.79-13963, 2005.
DOI : 10.1128/JVI.79.22.13963-13973.2005

G. Carloni, S. Iacovacci, M. Sargiacomo, G. Ravagnan, A. Ponzetto et al., Susceptibility of human liver cell cultures to hepatitis C virus infection, Arch Virol, vol.8, pp.31-39, 1993.
DOI : 10.1007/978-3-7091-9312-9_4

M. Carriere, V. Pene, A. Breiman, F. Conti, S. Chouzenoux et al., A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication, Journal of Medical Virology, vol.51, issue.2, pp.79-155, 2007.
DOI : 10.1002/jmv.20773

V. Castet, C. Fournier, A. Soulier, R. Brillet, J. Coste et al., Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro, Journal of Virology, vol.76, issue.16, pp.76-8189, 2002.
DOI : 10.1128/JVI.76.16.8189-8199.2002

J. Chang, J. T. Guo, D. Jiang, H. Guo, J. M. Taylor et al., Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells, Journal of Virology, vol.82, issue.16, pp.82-8215, 2008.
DOI : 10.1128/JVI.02575-07

K. S. Chang, J. Jiang, Z. Cai, and G. Luo, Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture, Journal of Virology, vol.81, issue.24, pp.81-13783, 2007.
DOI : 10.1128/JVI.01091-07

C. Chapel, C. Garcia, B. Bartosch, P. Roingeard, N. Zitzmann et al., Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors, Journal of General Virology, vol.88, issue.4, pp.88-1133, 2007.
DOI : 10.1099/vir.0.82465-0

W. Chen, Z. Zhang, J. Chen, J. Zhang, J. Zhang et al., HCV core protein interacts with Dicer to antagonize RNA silencing, Virus Research, vol.133, issue.2, pp.250-258, 2008.
DOI : 10.1016/j.virusres.2008.01.011

S. Chevaliez and J. M. Pawlotsky, Hepatitis C virus: Virology, diagnosis and management of antiviral therapy, World Journal of Gastroenterology, vol.13, issue.17, pp.2461-2466, 2007.
DOI : 10.3748/wjg.v13.i17.2461

S. Chevaliez and J. M. Pawlotsky, Interferon-based therapy of hepatitis C, Advanced Drug Delivery Reviews, vol.59, issue.12, pp.1222-1241, 2007.
DOI : 10.1016/j.addr.2007.07.002

S. H. Choi, S. Y. Kim, K. J. Park, Y. J. Kim, and S. B. Hwang, Hepatitis C Virus Core Protein Is Efficiently Released into the Culture Medium in Insect Cells, BMB Reports, vol.37, issue.6, pp.37-735, 2004.
DOI : 10.5483/BMBRep.2004.37.6.735

T. W. Chong, R. L. Smith, M. G. Hughes, J. Camden, C. K. Rudy et al., Primary Human Hepatocytes in Spheroid Formation to Study Hepatitis C Infection1, Journal of Surgical Research, vol.130, issue.1, pp.52-57, 2006.
DOI : 10.1016/j.jss.2005.04.043

Q. L. Choo, G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley et al., Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, vol.244, issue.4902, pp.244-359, 1989.
DOI : 10.1126/science.2523562

R. F. Clayton, A. Owsianka, J. Aitken, S. Graham, D. Bhella et al., Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles, J Virol, issue.15, pp.76-7672, 2002.

A. Codran, C. Royer, D. Jaeck, M. Bastien-valle, T. F. Baumert et al., Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis, Journal of General Virology, vol.87, issue.9, pp.2583-2593, 2006.
DOI : 10.1099/vir.0.81710-0

M. A. Connelly and D. L. Williams, Scavenger receptor BI: A scavenger receptor with a mission to transport high density lipoprotein lipids, Current Opinion in Lipidology, vol.15, issue.3, pp.287-295, 2004.
DOI : 10.1097/00041433-200406000-00008

E. G. Cormier, F. Tsamis, F. Kajumo, R. J. Durso, J. P. Gardner et al., CD81 is an entry coreceptor for hepatitis C virus, Proceedings of the National Academy of Sciences, vol.101, issue.19, pp.7270-7274, 2004.
DOI : 10.1073/pnas.0402253101

B. Cribier, C. Schmitt, A. Bingen, A. Kirn, and F. Keller, In vitro infection of peripheral blood mononuclear cells by hepatitis C virus, Journal of General Virology, vol.76, issue.10, pp.76-2485, 1995.
DOI : 10.1099/0022-1317-76-10-2485

H. Dansako, M. Ikeda, and N. Kato, Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes, Febs J, issue.16, pp.274-4161, 2007.

S. Dash, A. B. Halim, H. Tsuji, N. Hiramatsu, and M. A. Gerber, Transfection of HepG2 cells with infectious hepatitis C virus genome, Am J Pathol, vol.151, issue.2, pp.363-373, 1997.

O. De-bouteiller, E. Merck, U. A. Hasan, S. Hubac, B. Benguigui et al., Recognition of Double-stranded RNA by Human Toll-like Receptor 3 and Downstream Receptor Signaling Requires Multimerization and an Acidic pH, Journal of Biological Chemistry, vol.280, issue.46, pp.280-38133, 2005.
DOI : 10.1074/jbc.M507163200

D. Francesco, R. Migliaccio, and G. , Challenges and successes in developing new therapies for hepatitis C, Nature, vol.40, issue.7053, pp.436-953, 2005.
DOI : 10.1016/j.cbpa.2004.10.007

S. De-lucas, J. Bartolome, and V. Carreno, Hepatitis C Virus Core Protein Down???Regulates Transcription of Interferon???Induced Antiviral Genes, The Journal of Infectious Diseases, vol.191, issue.1, pp.93-99, 2005.
DOI : 10.1086/426509

S. Deforges, A. Evlashev, M. Perret, M. Sodoyer, S. Pouzol et al., Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo, Journal of General Virology, vol.85, issue.9, pp.85-2515, 2004.
DOI : 10.1099/vir.0.80071-0
URL : https://hal.archives-ouvertes.fr/inserm-00139572

O. Diaz, F. Delers, M. Maynard, S. Demignot, F. Zoulim et al., Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins, Journal of General Virology, vol.87, issue.10, pp.2983-2991, 2006.
DOI : 10.1099/vir.0.82033-0
URL : https://hal.archives-ouvertes.fr/inserm-00139590

M. Dreux, B. Boson, S. Ricard-blum, J. Molle, D. Lavillette et al., The Exchangeable Apolipoprotein ApoC-I Promotes Membrane Fusion of Hepatitis C Virus, Journal of Biological Chemistry, vol.282, issue.44, pp.282-32357, 2007.
DOI : 10.1074/jbc.M705358200
URL : https://hal.archives-ouvertes.fr/hal-00315131

M. Dreux, V. L. Dao-thi, J. Fresquet, M. Guerin, Z. Julia et al., Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains, PLoS Pathogens, vol.100, issue.2, p.1000310, 2009.
DOI : 10.1371/journal.ppat.1000310.s005

M. Dreux, T. Pietschmann, C. Granier, C. Voisset, S. Ricard-blum et al., High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI, Journal of Biological Chemistry, vol.281, issue.27, pp.281-18285, 2006.
DOI : 10.1074/jbc.M602706200
URL : https://hal.archives-ouvertes.fr/hal-00313930

J. Dubuisson, F. Helle, and L. Cocquerel, Early steps of the hepatitis C virus life cycle, Cellular Microbiology, vol.20, issue.4, pp.821-827, 2008.
DOI : 10.1073/pnas.0503596102

D. Egger, B. Wolk, R. Gosert, L. Bianchi, H. E. Blum et al., Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex, Journal of Virology, vol.76, issue.12, pp.76-5974, 2002.
DOI : 10.1128/JVI.76.12.5974-5984.2002

M. A. El-farrash, H. H. Aly, K. Watashi, M. Hijikata, H. Egawa et al., Infection of Immortalized Primary Hepatocytes by HCV Genotype 4a and Inhibition of Virus Replication by Cyclosporin, Microbiology and Immunology, vol.132, issue.2, pp.127-133, 2007.
DOI : 10.1111/j.1348-0421.2007.tb03883.x

G. A. Elmowalid, M. Qiao, S. H. Jeong, B. B. Borg, T. F. Baumert et al., Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees, Proceedings of the National Academy of Sciences, vol.104, issue.20, pp.104-8427, 2007.
DOI : 10.1073/pnas.0702162104

A. K. Erickson, S. Seiwert, M. Gale, and . Jr, Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon- alpha2b against hepatitis C virus infection, Antivir Ther, issue.7, pp.13-851, 2008.

C. Esau, S. Davis, S. F. Murray, X. X. Yu, S. K. Pandey et al., miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting, Cell Metabolism, vol.3, issue.2, pp.87-98, 2006.
DOI : 10.1016/j.cmet.2006.01.005

V. Escuret, A. Martin, D. Durantel, R. Parent, O. Hantz et al., Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system, Antimicrob Agents Chemother, issue.12, pp.50-3984, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00134586

H. J. Ezelle, D. Markovic, and G. N. Barber, Generation of Hepatitis C Virus-Like Particles by Use of a Recombinant Vesicular Stomatitis Virus Vector, Journal of Virology, vol.76, issue.23, pp.76-12325, 2002.
DOI : 10.1128/JVI.76.23.12325-12334.2002

C. Failla, L. Tomei, and R. De-francesco, An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A, J Virol, vol.69, issue.3, pp.1769-1777, 1995.

P. Farci, I. Quinti, S. Farci, H. J. Alter, R. Strazzera et al., Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively, Proceedings of the National Academy of Sciences, vol.103, issue.22, pp.8475-8480, 2006.
DOI : 10.1073/pnas.0602546103

S. Farley, A double whammy for hep C, Nature Reviews Drug Discovery, issue.2, p.419, 2003.

M. J. Farquhar and J. A. Mckeating, Primary hepatocytes as targets for Hepatitis C virus replication, Journal of Viral Hepatitis, vol.282, issue.2, pp.849-854, 2008.
DOI : 10.1111/j.1365-2893.2008.01051.x

K. A. Fitzgerald, D. C. Rowe, B. J. Barnes, D. R. Caffrey, A. Visintin et al., LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF, J Exp Med, issue.7, pp.198-1043, 2003.

M. Flint, J. M. Thomas, C. M. Maidens, C. Shotton, S. Levy et al., Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein, J Virol, issue.8, pp.73-6782, 1999.

C. Forster, Tight junctions and the modulation of barrier function in disease, Histochemistry and Cell Biology, vol.243, issue.Pt 9, pp.55-70, 2008.
DOI : 10.1007/s00418-008-0424-9

C. Fournier, C. Sureau, J. Coste, J. Ducos, G. Pageaux et al., In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus., Journal of General Virology, vol.79, issue.10, pp.79-2367, 1998.
DOI : 10.1099/0022-1317-79-10-2367

E. Foy, K. Li, C. Wang, R. Sumpter, . Jr et al., Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease, Science, vol.300, issue.5622, pp.300-1145, 2003.
DOI : 10.1126/science.1082604

L. Frelin, E. D. Brenndorfer, G. Ahlen, M. Weiland, C. Hultgren et al., The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor ?? mediated liver disease, Gut, vol.55, issue.10, pp.55-1475, 2006.
DOI : 10.1136/gut.2005.085050

P. Friebe, V. Lohmann, N. Krieger, and R. Bartenschlager, Sequences in the 5' Nontranslated Region of Hepatitis C Virus Required for RNA Replication, Journal of Virology, vol.75, issue.24, pp.75-12047, 2001.
DOI : 10.1128/JVI.75.24.12047-12057.2001

M. Furuse, K. Fujita, T. Hiiragi, K. Fujimoto, and S. Tsukita, Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin, The Journal of Cell Biology, vol.110, issue.7, pp.141-1539, 1998.
DOI : 10.1083/jcb.120.2.477

M. Gale, . Jr, C. M. Blakely, B. Kwieciszewski, S. L. Tan et al., Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation, Molecular and Cellular Biology, vol.18, issue.9, pp.5208-5218, 1998.
DOI : 10.1128/MCB.18.9.5208

M. Gale, . Jr, and E. M. Foy, Evasion of intracellular host defence by hepatitis C virus, Nature, issue.7053, pp.436-939, 2005.

L. Gao, H. Aizaki, J. W. He, and M. M. Lai, Interactions between Viral Nonstructural Proteins and Host Protein hVAP-33 Mediate the Formation of Hepatitis C Virus RNA Replication Complex on Lipid Raft, Journal of Virology, vol.78, issue.7, pp.78-3480, 2004.
DOI : 10.1128/JVI.78.7.3480-3488.2004

P. Gee, P. K. Chua, J. Gevorkyan, K. Klumpp, I. Najera et al., Essential Role of the N-terminal Domain in the Regulation of RIG-I ATPase Activity, Journal of Biological Chemistry, vol.283, issue.14, pp.283-9488, 2008.
DOI : 10.1074/jbc.M706777200

C. Girard, M. Ravallec, M. Mariller, J. P. Bossy, A. Cahour et al., Effect of the 5' non-translated region on self-assembly of hepatitis C virus genotype 1a structural proteins produced in insect cells, Journal of General Virology, vol.85, issue.12, pp.85-3659, 2004.
DOI : 10.1099/vir.0.79909-0

S. Girard, P. Shalhoub, P. Lescure, A. Sabile, D. E. Misek et al., An Altered Cellular Response to Interferon and Up-Regulation of Interleukin-8 Induced by the Hepatitis C Viral Protein NS5A Uncovered by Microarray Analysis, Virology, vol.295, issue.2, pp.295-272, 2002.
DOI : 10.1006/viro.2002.1373

M. J. Gomez-lechon, J. V. Castell, and M. T. Donato, Hepatocytes???the choice to investigate drug metabolism and toxicity in man: In vitro variability as a reflection of in vivo, Chemico-Biological Interactions, vol.168, issue.1, pp.30-50, 2007.
DOI : 10.1016/j.cbi.2006.10.013

G. Z. Gong, Y. F. Jiang, Y. He, L. Y. Lai, Y. H. Zhu et al., HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding, World J Gastroenterol, issue.15, pp.10-2223, 2004.

M. A. Gonzalez-carmona, S. Schussler, M. Serwe, M. Alt, J. Ludwig et al., Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells, Journal of Hepatology, vol.44, issue.6, pp.44-1017, 2006.
DOI : 10.1016/j.jhep.2005.10.022

R. Gosert, D. Egger, V. Lohmann, R. Bartenschlager, H. E. Blum et al., Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons, Journal of Virology, vol.77, issue.9, pp.77-5487, 2003.
DOI : 10.1128/JVI.77.9.5487-5492.2003

J. M. Gottwein, T. K. Scheel, A. M. Hoegh, J. B. Lademann, J. Eugen-olsen et al., Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a, S52/JFH1) viruses. Gastroenterology, pp.2-133, 2007.
DOI : 10.1053/j.gastro.2007.08.005

J. Grove, T. Huby, Z. Stamataki, T. Vanwolleghem, P. Meuleman et al., Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity, Journal of Virology, vol.81, issue.7, pp.81-3162, 2007.
DOI : 10.1128/JVI.02356-06
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866051

C. Guguen-guillouzo, M. Bourel, and A. Guillouzo, Human Hepatocyte Cultures, Prog Liver Dis, vol.8, pp.33-50, 1986.
DOI : 10.1016/B978-0-12-461201-3.50030-X

A. Guillouzo, Liver cell models in in vitro toxicology, Environmental Health Perspectives, vol.106, issue.Suppl 2, pp.511-532, 1998.
DOI : 10.1289/ehp.98106511

J. T. Guo, V. V. Bichko, and C. Seeger, Effect of Alpha Interferon on the Hepatitis C Virus Replicon, Journal of Virology, vol.75, issue.18, pp.75-8516, 2001.
DOI : 10.1128/JVI.75.18.8516-8523.2001

A. Haberstroh, E. K. Schnober, M. B. Zeisel, P. Carolla, H. Barth et al., Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Postbinding Steps and Membrane Fusion, Gastroenterology, vol.135, issue.5, pp.135-1719, 2008.
DOI : 10.1053/j.gastro.2008.07.018

H. J. Harris, M. J. Farquhar, C. J. Mee, C. Davis, G. M. Reynolds et al., CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry, Journal of Virology, vol.82, issue.10, pp.82-5007, 2008.
DOI : 10.1128/JVI.02286-07

M. Hassan, H. Ghozlan, and O. Kader, Activation of RB/E2F signaling pathway is required for the modulation of hepatitis C virus core protein-induced cell growth in liver and non-liver cells, Cellular Signalling, vol.16, issue.12, pp.16-1375, 2004.
DOI : 10.1016/j.cellsig.2004.04.005

N. Hayashi and T. Takehara, Antiviral therapy for chronic hepatitis C: past, present, and future, Journal of Gastroenterology, vol.129, issue.Suppl 2, pp.17-27, 2006.
DOI : 10.1007/s00535-005-1740-7

S. Hazari, L. Taylor, S. Haque, R. F. Garry, S. Florman et al., Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in Hepatitis C virus replicon, Virology Journal, vol.4, issue.1, p.89, 2007.
DOI : 10.1186/1743-422X-4-89

Y. He, M. S. King, D. J. Kempf, L. Lu, H. B. Lim et al., Relative Replication Capacity and Selective Advantage Profiles of Protease Inhibitor-Resistant Hepatitis C Virus (HCV) NS3 Protease Mutants in the HCV Genotype 1b Replicon System, Antimicrobial Agents and Chemotherapy, vol.52, issue.3, pp.1101-1110, 2008.
DOI : 10.1128/AAC.01149-07

F. Helle, C. Wychowski, N. Vu-dac, K. R. Gustafson, C. Voisset et al., Cyanovirin-N Inhibits Hepatitis C Virus Entry by Binding to Envelope Protein Glycans, Journal of Biological Chemistry, vol.281, issue.35, pp.281-25177, 2006.
DOI : 10.1074/jbc.M602431200
URL : https://hal.archives-ouvertes.fr/hal-00105507

T. Heller, S. Saito, J. Auerbach, T. Williams, T. R. Moreen et al., An in vitro model of hepatitis C virion production, Proceedings of the National Academy of Sciences, vol.102, issue.7, pp.2579-2583, 2005.
DOI : 10.1073/pnas.0409666102

H. Hemmes, L. Lakatos, R. Goldbach, J. Burgyan, and M. Prins, The NS3 protein of Rice hoja blanca tenuivirus suppresses RNA silencing in plant and insect hosts by efficiently binding both siRNAs and miRNAs, RNA, vol.13, issue.7, pp.13-1079, 2007.
DOI : 10.1261/rna.444007

J. I. Henke, D. Goergen, J. Zheng, Y. Song, C. G. Schuttler et al., microRNA-122 stimulates translation of hepatitis C virus RNA, The EMBO Journal, vol.118, issue.24, pp.27-3300, 2008.
DOI : 10.1038/emboj.2008.244

S. D. Henry, H. J. Metselaar, R. C. Lonsdale, A. Kok, B. L. Haagmans et al., Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha, Gastroenterology, issue.5, pp.131-1452, 2006.

S. D. Henry, P. Van-der-wegen, H. J. Metselaar, H. W. Tilanus, B. J. Scholte et al., Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes, Molecular Therapy, vol.14, issue.4, pp.485-493, 2006.
DOI : 10.1016/j.ymthe.2006.04.012

T. H. Heo, S. M. Lee, B. Bartosch, F. L. Cosset, and C. Y. Kang, Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein, Virus Research, vol.121, issue.1, pp.58-64, 2006.
DOI : 10.1016/j.virusres.2006.04.002

K. J. Herlihy, J. P. Graham, R. Kumpf, A. K. Patick, R. Duggal et al., Development of Intergenotypic Chimeric Replicons To Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase Inhibitors, Antimicrobial Agents and Chemotherapy, vol.52, issue.10, pp.52-3523, 2008.
DOI : 10.1128/AAC.00533-08

B. I. Hernandez-santiago, T. Beltran, L. Stuyver, C. K. Chu, and R. F. Schinazi, Metabolism of the anti-hepatitis C virus nucleoside beta-D-N4-hydroxycytidine in different liver cells, Antimicrob Agents Chemother, issue.12, pp.48-4636, 2004.

N. J. Hewitt, M. J. Lechon, J. B. Houston, D. Hallifax, H. S. Brown et al., Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies, Drug Metabolism Reviews, vol.290, issue.19, pp.159-234, 2007.
DOI : 10.2337/diabetes.50.3.521

R. N. Hines, The ontogeny of drug metabolism enzymes and implications for adverse drug events, Pharmacology & Therapeutics, vol.118, issue.2, pp.250-267, 2008.
DOI : 10.1016/j.pharmthera.2008.02.005

J. Hiscott, R. Lin, P. Nakhaei, and S. Paz, MasterCARD: a priceless link to innate immunity, Trends in Molecular Medicine, vol.12, issue.2, pp.53-56, 2006.
DOI : 10.1016/j.molmed.2005.12.003

N. Horscroft, V. C. Lai, W. Cheney, N. Yao, J. Z. Wu et al., Replicon Cell Culture System as a Valuable Tool in Antiviral Drug Discovery against Hepatitis C Virus, Antiviral Chemistry and Chemotherapy, vol.77, issue.1, pp.1-12, 2005.
DOI : 10.1126/science.285.5424.110

M. Houghton, A. Weiner, J. Han, G. Kuo, and Q. L. Choo, Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease, Hepatology, vol.260, issue.2, pp.381-388, 1991.
DOI : 10.1002/hep.1840140227

C. Hourioux, M. Ait-goughoulte, R. Patient, D. Fouquenet, F. Arcanger-doudet et al., Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane, Cellular Microbiology, vol.72, issue.6, pp.1014-1027, 2007.
DOI : 10.1073/pnas.0503596102
URL : https://hal.archives-ouvertes.fr/inserm-00137282

M. Hsu, J. Zhang, M. Flint, C. Logvinoff, C. Cheng-mayer et al., Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles, Proceedings of the National Academy of Sciences, vol.100, issue.12, pp.7271-7276, 2003.
DOI : 10.1073/pnas.0832180100

H. Huang, F. Sun, D. M. Owen, W. Li, Y. Chen et al., Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins, Proceedings of the National Academy of Sciences, vol.104, issue.14, pp.104-5848, 2007.
DOI : 10.1073/pnas.0700760104

P. Huang, D. A. Goff, Q. Huang, A. Martinez, X. Xu et al., Discovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus Replication, Antimicrobial Agents and Chemotherapy, vol.52, issue.4, pp.1419-1429, 2008.
DOI : 10.1128/AAC.00525-07

S. Iacovacci, A. Manzin, S. Barca, M. Sargiacomo, A. Serafino et al., Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro., Hepatology, vol.26, issue.5, pp.26-1328, 1997.
DOI : 10.1053/jhep.1997.v26.pm0009362380

M. Ikeda, K. Abe, H. Dansako, T. Nakamura, K. Naka et al., Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system, Biochemical and Biophysical Research Communications, vol.329, issue.4, pp.1350-1359, 2005.
DOI : 10.1016/j.bbrc.2005.02.138

M. Ikeda and N. Kato, Modulation of host metabolism as a target of new antivirals, Advanced Drug Delivery Reviews, vol.59, issue.12, pp.1277-1289, 2007.
DOI : 10.1016/j.addr.2007.03.021

M. Ikeda, K. Sugiyama, T. Mizutani, T. Tanaka, K. Tanaka et al., Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus, Virus Research, vol.56, issue.2, pp.157-167, 1998.
DOI : 10.1016/S0168-1702(98)00063-X

T. Ito, J. Mukaigawa, J. Zuo, Y. Hirabayashi, K. Mitamura et al., Cultivation of hepatitis C virus in primary hepatocyte culture from patients with chronic hepatitis C results in release of high titre infectious virus, Journal of General Virology, vol.77, issue.5, pp.77-1043, 1996.
DOI : 10.1099/0022-1317-77-5-1043

D. Jarczak, M. Korf, C. Beger, M. P. Manns, and M. Kruger, Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons, FEBS Journal, vol.43, issue.Suppl. 1, pp.272-5910, 2005.
DOI : 10.1111/j.1742-4658.2005.04986.x

S. H. Jeong, M. Qiao, M. Nascimbeni, Z. Hu, B. Rehermann et al., Immunization with Hepatitis C Virus-Like Particles Induces Humoral and Cellular Immune Responses in Nonhuman Primates, Journal of Virology, vol.78, issue.13, pp.78-6995, 2004.
DOI : 10.1128/JVI.78.13.6995-7003.2004

J. Ji, A. Glaser, M. Wernli, J. M. Berke, D. Moradpour et al., Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus, Journal of General Virology, vol.89, issue.11, pp.89-2761, 2008.
DOI : 10.1099/vir.0.2008/002923-0

D. Jiang, H. Guo, C. Xu, J. Chang, B. Gu et al., Identification of Three Interferon-Inducible Cellular Enzymes That Inhibit the Replication of Hepatitis C Virus, Journal of Virology, vol.82, issue.4, pp.1665-1678, 2008.
DOI : 10.1128/JVI.02113-07

I. B. Johnsen, T. T. Nguyen, M. Ringdal, A. M. Tryggestad, O. Bakke et al., Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling, The EMBO Journal, vol.301, issue.14, pp.25-3335, 2006.
DOI : 10.1038/sj.emboj.7601222

C. L. Jopling, K. L. Norman, and P. Sarnow, Positive and Negative Modulation of Viral and Cellular mRNAs by Liver-specific MicroRNA miR-122, Cold Spring Harbor Symposia on Quantitative Biology, vol.68, issue.0, pp.369-376, 2006.
DOI : 10.1016/S1097-2765(02)00541-5

C. L. Jopling, S. Schutz, and P. Sarnow, Position-Dependent Function for a Tandem MicroRNA miR-122-Binding Site Located in the Hepatitis C Virus RNA Genome, Cell Host & Microbe, vol.4, issue.1, pp.77-85, 2008.
DOI : 10.1016/j.chom.2008.05.013

C. L. Jopling, M. Yi, A. M. Lancaster, S. M. Lemon, and P. Sarnow, Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA, Science, vol.309, issue.5740, pp.309-1577, 2005.
DOI : 10.1126/science.1113329

R. Jover, R. Bort, M. J. Gomez-lechon, and J. V. Castell, Re-expression of C/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells, FEBS Lett, issue.2, pp.431-227, 1998.

T. Kanda, A. Basu, R. Steele, T. Wakita, J. S. Ryerse et al., Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes, Journal of Virology, vol.80, issue.9, pp.4633-4639, 2006.
DOI : 10.1128/JVI.80.9.4633-4639.2006

T. Kanda, R. Steele, R. Ray, and R. B. Ray, Hepatitis C Virus Infection Induces the Beta Interferon Signaling Pathway in Immortalized Human Hepatocytes, Journal of Virology, vol.81, issue.22, pp.81-12375, 2007.
DOI : 10.1128/JVI.01695-07

T. Kanto, N. Hayashi, T. Takehara, H. Hagiwara, E. Mita et al., Density analysis of hepatitis C virus particle population in the circulation of infected hosts: implications for virus neutralization or persistence, Journal of Hepatology, vol.22, issue.4, pp.440-448, 1995.
DOI : 10.1016/0168-8278(95)80107-3

S. B. Kapadia, H. Barth, T. Baumert, J. A. Mckeating, and F. V. Chisari, Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I, Journal of Virology, vol.81, issue.1, pp.374-383, 2007.
DOI : 10.1128/JVI.01134-06

S. B. Kapadia and F. V. Chisari, Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids, Proceedings of the National Academy of Sciences, vol.102, issue.7, pp.2561-2566, 2005.
DOI : 10.1073/pnas.0409834102

T. Kato, T. Date, M. Miyamoto, A. Furusaka, K. Tokushige et al., Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon, Gastroenterology, vol.125, issue.6, pp.125-1808, 2003.
DOI : 10.1053/j.gastro.2003.09.023

T. Kato, T. Matsumura, T. Heller, S. Saito, R. K. Sapp et al., O.172 Production of infectious hepatitis C virus of various genotypes in cell culture, Journal of Clinical Virology, vol.36, issue.9, pp.81-4405, 2007.
DOI : 10.1016/S1386-6532(06)80162-9
URL : https://hal.archives-ouvertes.fr/in2p3-00005139

P. Keskinen, M. Nyqvist, T. Sareneva, J. Pirhonen, K. Melen et al., Impaired Antiviral Response in Human Hepatoma Cells, Virology, vol.263, issue.2, pp.364-375, 1999.
DOI : 10.1006/viro.1999.9983

K. S. Khabar, F. Al-zoghaibi, M. N. Al-ahdal, T. Murayama, M. Dhalla et al., The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha, J Exp Med, issue.7, pp.186-1077, 1997.

S. S. Kim, L. F. Peng, W. Lin, W. H. Choe, N. Sakamoto et al., A Cell-Based, High-Throughput Screen for Small Molecule Regulators of Hepatitis C Virus Replication, Gastroenterology, vol.132, issue.1, pp.311-320, 2007.
DOI : 10.1053/j.gastro.2006.10.032

K. Klumpp, G. Kalayanov, H. Ma, L. Pogam, S. Leveque et al., 2'-Deoxy-4'-azido Nucleoside Analogs Are Highly Potent Inhibitors of Hepatitis C Virus Replication Despite the Lack of 2'-??-Hydroxyl Groups, Journal of Biological Chemistry, vol.283, issue.4, pp.2167-2175, 2008.
DOI : 10.1074/jbc.M708929200

A. A. Kolykhalov, K. Mihalik, S. M. Feinstone, and C. M. Rice, Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3' Nontranslated Region Are Essential for Virus Replication In Vivo, Journal of Virology, vol.74, issue.4, pp.2046-2051, 2000.
DOI : 10.1128/JVI.74.4.2046-2051.2000

M. Korf, A. Meyer, D. Jarczak, C. Beger, M. P. Manns et al., Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters, Journal of Viral Hepatitis, vol.72, issue.6, pp.122-132, 2007.
DOI : 10.1128/JVI.79.11.7050-7058.2005

G. Koutsoudakis, E. Herrmann, S. Kallis, R. Bartenschlager, and T. Pietschmann, The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells, Journal of Virology, vol.81, issue.2, pp.588-598, 2007.
DOI : 10.1128/JVI.01534-06

. Ikki, IKKepsilon plays a key role in integrating signals induced by pro-inflammatory stimuli, J Biol Chem, vol.278, issue.29, pp.26612-26619

M. Krieger, Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems, Journal of Clinical Investigation, vol.108, issue.6, pp.793-797, 2001.
DOI : 10.1172/JCI14011

N. Krieger, V. Lohmann, and R. Bartenschlager, Enhancement of Hepatitis C Virus RNA Replication by Cell Culture-Adaptive Mutations, Journal of Virology, vol.75, issue.10, pp.75-4614, 2001.
DOI : 10.1128/JVI.75.10.4614-4624.2001

L. M. Lagging, K. Meyer, R. J. Owens, and R. Ray, Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus, J Virol, issue.5, pp.72-3539, 1998.

R. E. Lanford, B. Guerra, H. Lee, D. R. Averett, B. Pfeiffer et al., Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons, Journal of Virology, vol.77, issue.2, pp.1092-1104, 2003.
DOI : 10.1128/JVI.77.2.1092-1104.2003

M. Lavie, A. Goffard, and J. Dubuisson, Assembly of a functional HCV glycoprotein heterodimer, Curr Issues Mol Biol, vol.9, issue.2, pp.71-86, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00183316

M. Lavie, C. Voisset, N. Vu-dac, V. Zurawski, G. Duverlie et al., Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system, Hepatology, vol.71, issue.6, pp.44-1626, 2006.
DOI : 10.1002/hep.21406
URL : https://hal.archives-ouvertes.fr/hal-00183312

D. Lavillette, Y. Morice, G. Germanidis, P. Donot, A. Soulier et al., Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection, Journal of Virology, vol.79, issue.10, pp.79-6023, 2005.
DOI : 10.1128/JVI.79.10.6023-6034.2005

D. Lavillette, A. W. Tarr, C. Voisset, P. Donot, B. Bartosch et al., Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus, Hepatology, vol.82, issue.2, pp.41-265, 2005.
DOI : 10.1002/hep.20542

C. A. Lazaro, M. Chang, W. Tang, J. Campbell, D. G. Sullivan et al., Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes, The American Journal of Pathology, vol.170, issue.2, pp.478-489, 2007.
DOI : 10.2353/ajpath.2007.060789

L. Guillou-guillemette, H. Vallet, S. Gaudy-graffin, C. Payan, C. Pivert et al., Genetic diversity of the hepatitis C virus: Impact and issues in the antiviral therapy, World Journal of Gastroenterology, vol.13, issue.17, pp.13-2416, 2007.
DOI : 10.3748/wjg.v13.i17.2416

H. Y. Lee, J. H. Yum, Y. K. Rho, S. J. Oh, H. S. Choi et al., Inhibition of HCV Replicon Cell Growth by 2-Arylbenzofuran Derivatives Isolated from Mori Cortex Radicis, Planta Medica, vol.73, issue.14, pp.73-1481, 2007.
DOI : 10.1055/s-2007-990249

S. H. Lee, Y. K. Kim, C. S. Kim, S. K. Seol, J. Kim et al., E2 of Hepatitis C Virus Inhibits Apoptosis, The Journal of Immunology, vol.175, issue.12, pp.175-8226, 2005.
DOI : 10.4049/jimmunol.175.12.8226

H. Lerat, F. Berby, M. A. Trabaud, O. Vidalin, M. Major et al., Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells., Journal of Clinical Investigation, vol.97, issue.3, pp.97-845, 1996.
DOI : 10.1172/JCI118485

G. Z. Leu, T. Y. Lin, and J. T. Hsu, Anti-HCV activities of selective polyunsaturated fatty acids, Biochemical and Biophysical Research Communications, vol.318, issue.1, pp.318-275, 2004.
DOI : 10.1016/j.bbrc.2004.04.019

K. Li, Z. Chen, N. Kato, M. Gale, . Jr et al., Distinct poly(I-C) and virusactivated signaling pathways leading to interferon-beta production in hepatocytes, J Biol Chem, issue.17, pp.280-16739, 2005.

K. Li, E. Foy, J. C. Ferreon, M. Nakamura, A. C. Ferreon et al., Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Tolllike receptor 3 adaptor protein TRIF, Proc Natl Acad Sci, issue.8, pp.102-2992, 2005.

Y. Liang, H. Ishida, O. Lenz, T. I. Lin, O. Nyanguile et al., Antiviral Suppression vs Restoration of RIG-I Signaling by Hepatitis C Protease and Polymerase Inhibitors, Gastroenterology, vol.135, issue.5, pp.135-1710, 2008.
DOI : 10.1053/j.gastro.2008.07.023

C. Lin, B. M. Pragai, A. Grakoui, J. Xu, and C. M. Rice, Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics, J Virol, issue.12, pp.68-8147, 1994.
DOI : 10.1073/pnas.92.17.7622
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC41197

R. Lin, L. Yang, P. Nakhaei, Q. Sun, E. Sharif-askari et al., Negative Regulation of the Retinoic Acid-inducible Gene I-induced Antiviral State by the Ubiquitin-editing Protein A20, Journal of Biological Chemistry, vol.281, issue.4, pp.2095-2103, 2006.
DOI : 10.1074/jbc.M510326200

B. D. Lindenbach, M. J. Evans, A. J. Syder, B. Wolk, T. L. Tellinghuisen et al., Complete Replication of Hepatitis C Virus in Cell Culture, Science, vol.309, issue.5734, pp.309-623, 2005.
DOI : 10.1126/science.1114016

B. D. Lindenbach, P. Meuleman, A. Ploss, T. Vanwolleghem, A. J. Syder et al., Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro, Proceedings of the National Academy of Sciences, vol.103, issue.10, pp.3805-3809, 2006.
DOI : 10.1073/pnas.0511218103

S. Liu, W. Yang, L. Shen, J. R. Turner, C. B. Coyne et al., Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection, Journal of Virology, vol.83, issue.4, pp.2011-2014, 2009.
DOI : 10.1128/JVI.01888-08

V. Lohmann, S. Hoffmann, U. Herian, F. Penin, and R. Bartenschlager, Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture, Journal of Virology, vol.77, issue.5, pp.77-3007, 2003.
DOI : 10.1128/JVI.77.5.3007-3019.2003
URL : https://hal.archives-ouvertes.fr/hal-00313699

V. Lohmann, F. Korner, A. Dobierzewska, and R. Bartenschlager, Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation, Journal of Virology, vol.75, issue.3, pp.1437-1449, 2001.
DOI : 10.1128/JVI.75.3.1437-1449.2001

V. Lohmann, F. Korner, J. Koch, U. Herian, L. Theilmann et al., Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line, Science, vol.285, issue.5424, pp.285-110, 1999.
DOI : 10.1126/science.285.5424.110

M. A. Loriot, J. P. Bronowicki, D. Lagorce, F. Lakehal, T. Persico et al., Permissiveness of human biliary epithelial cells to infection by hepatitis C virus, Hepatology, vol.71, issue.5, pp.29-1587, 1999.
DOI : 10.1002/hep.510290527

H. Ma, W. R. Jiang, N. Robledo, V. Leveque, S. Ali et al., Characterization of the Metabolic Activation of Hepatitis C Virus Nucleoside Inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and Identification of a Novel Active 5'-Triphosphate Species, Journal of Biological Chemistry, vol.282, issue.41, pp.282-29812, 2007.
DOI : 10.1074/jbc.M705274200

P. Maillard, T. Huby, U. Andreo, M. Moreau, J. Chapman et al., The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins, The FASEB Journal, vol.20, issue.6, pp.735-737, 2006.
DOI : 10.1096/fj.05-4728fje

M. Majumder, A. K. Ghosh, R. Steele, X. Y. Zhou, N. J. Phillips et al., Hepatitis C Virus NS5A Protein Impairs TNF-Mediated Hepatic Apoptosis, but Not by an Anti-FAS Antibody, in Transgenic Mice, Virology, vol.294, issue.1, pp.94-105, 2002.
DOI : 10.1006/viro.2001.1309

M. Martell, J. I. Esteban, J. Quer, J. Genesca, A. Weiner et al., Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution, J Virol, issue.5, pp.66-3225, 1992.

T. Masaki, R. Suzuki, K. Murakami, H. Aizaki, K. Ishii et al., Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles, Journal of Virology, vol.82, issue.16, pp.82-7964, 2008.
DOI : 10.1128/JVI.00826-08

K. Matsui, Y. Kumagai, H. Kato, S. Sato, T. Kawagoe et al., Cutting Edge: Role of TANK-Binding Kinase 1 and Inducible I??B Kinase in IFN Responses against Viruses in Innate Immune Cells, The Journal of Immunology, vol.177, issue.9, pp.5785-5789, 2006.
DOI : 10.4049/jimmunol.177.9.5785

M. Matsumoto, S. B. Hwang, K. S. Jeng, N. Zhu, and M. M. Lai, Homotypic Interaction and Multimerization of Hepatitis C Virus Core Protein, Virology, vol.218, issue.1, pp.43-51, 1996.
DOI : 10.1006/viro.1996.0164

M. Matsumoto and T. Seya, TLR3: Interferon induction by double-stranded RNA including poly(I:C)???, Advanced Drug Delivery Reviews, vol.60, issue.7, pp.805-812, 2008.
DOI : 10.1016/j.addr.2007.11.005

Y. Matsuura, H. Tani, K. Suzuki, T. Kimura-someya, R. Suzuki et al., Characterization of Pseudotype VSV Possessing HCV Envelope Proteins, Virology, vol.286, issue.2, pp.263-275, 2001.
DOI : 10.1006/viro.2001.0971

J. A. Mckeating, L. Q. Zhang, C. Logvinoff, M. Flint, J. Zhang et al., Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner, Journal of Virology, vol.78, issue.16, pp.78-8496, 2004.
DOI : 10.1128/JVI.78.16.8496-8505.2004

C. J. Mee, J. Grove, H. J. Harris, K. Hu, P. Balfe et al., Effect of Cell Polarization on Hepatitis C Virus Entry, Journal of Virology, vol.82, issue.1, pp.461-470, 2008.
DOI : 10.1128/JVI.01894-07

L. Meertens, C. Bertaux, L. Cukierman, E. Cormier, D. Lavillette et al., The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus, Journal of Virology, vol.82, issue.7, pp.82-3555, 2008.
DOI : 10.1128/JVI.01977-07

L. Meertens, C. Bertaux, and T. Dragic, Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles, Journal of Virology, vol.80, issue.23, pp.80-11571, 2006.
DOI : 10.1128/JVI.01717-06

P. Meuleman, J. Hesselgesser, M. Paulson, T. Vanwolleghem, I. Desombere et al., Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo, Hepatology, vol.8, issue.6, pp.48-1761, 2008.
DOI : 10.1002/hep.22547

J. C. Meunier, R. E. Engle, K. Faulk, M. Zhao, B. Bartosch et al., Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1, Proceedings of the National Academy of Sciences, vol.102, issue.12, pp.4560-4565, 2005.
DOI : 10.1073/pnas.0501275102

J. C. Meunier, R. S. Russell, R. E. Engle, K. N. Faulk, R. H. Purcell et al., Apolipoprotein C1 Association with Hepatitis C Virus, Journal of Virology, vol.82, issue.19, pp.82-9647, 2008.
DOI : 10.1128/JVI.00914-08

E. F. Meurs and A. Breiman, The interferon inducing pathways and the hepatitis C virus, World Journal of Gastroenterology, vol.13, issue.17, pp.2446-2454, 2007.
DOI : 10.3748/wjg.v13.i17.2446

E. Meylan, J. Curran, K. Hofmann, D. Moradpour, M. Binder et al., Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus, Nature, vol.69, issue.7062, pp.437-1167, 2005.
DOI : 10.1016/j.cell.2005.08.012

H. Miyamoto, H. Okamoto, K. Sato, T. Tanaka, and S. Mishiro, Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction, Journal of General Virology, vol.73, issue.3, pp.73-715, 1992.
DOI : 10.1099/0022-1317-73-3-715

S. Molina, V. Castet, C. Fournier-wirth, L. Pichard-garcia, R. Avner et al., The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus, Journal of Hepatology, vol.46, issue.3, pp.411-419, 2007.
DOI : 10.1016/j.jhep.2006.09.024
URL : https://hal.archives-ouvertes.fr/inserm-00374413

S. Molina, V. Castet, L. Pichard-garcia, C. Wychowski, E. Meurs et al., Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent, Journal of Virology, vol.82, issue.1, pp.569-574, 2008.
DOI : 10.1128/JVI.01443-07
URL : https://hal.archives-ouvertes.fr/inserm-00374410

A. Molla, S. Vasavanonda, G. Kumar, H. L. Sham, M. Johnson et al., Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus, Virology, vol.250, issue.2, pp.255-262, 1998.
DOI : 10.1006/viro.1998.9383

D. Moradpour, M. J. Evans, R. Gosert, Z. Yuan, H. E. Blum et al., Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes, Journal of Virology, vol.78, issue.14, pp.78-7400, 2004.
DOI : 10.1128/JVI.78.14.7400-7409.2004

K. Moriishi and Y. Matsuura, Host factors involved in the replication of hepatitis C virus, Reviews in Medical Virology, vol.94, issue.5, pp.343-354, 2007.
DOI : 10.1002/rmv.542

K. Morikawa, Z. Zhao, T. Date, M. Miyamoto, A. Murayama et al., The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles, Journal of Medical Virology, vol.102, issue.6, pp.79-714, 2007.
DOI : 10.1002/jmv.20842

K. Murakami, Y. Inoue, S. S. Hmwe, K. Omata, T. Hongo et al., Dynamic behavior of hepatitis C virus quasispecies in a long-term culture of the three-dimensional radial-flow bioreactor system, Journal of Virological Methods, vol.148, issue.1-2, pp.174-181, 2008.
DOI : 10.1016/j.jviromet.2007.11.001

K. Murakami, K. Ishii, Y. Ishihara, S. Yoshizaki, K. Tanaka et al., Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b, Virology, vol.351, issue.2, pp.351-381, 2006.
DOI : 10.1016/j.virol.2006.03.038

Y. Murakami, H. H. Aly, A. Tajima, I. Inoue, and K. Shimotohno, Regulation of the hepatitis C virus genome replication by miR-199a, Journal of Hepatology, vol.50, issue.3, pp.50-453, 2009.
DOI : 10.1016/j.jhep.2008.06.010

K. Murata, M. Lechmann, M. Qiao, T. Gunji, H. J. Alter et al., Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection, Proceedings of the National Academy of Sciences, vol.100, issue.11, pp.100-6753, 2003.
DOI : 10.1073/pnas.1131929100

K. Naka, M. Ikeda, K. Abe, H. Dansako, and N. Kato, Mizoribine inhibits hepatitis C virus RNA replication: Effect of combination with interferon-??, Biochemical and Biophysical Research Communications, vol.330, issue.3, pp.330-871, 2005.
DOI : 10.1016/j.bbrc.2005.03.062

M. Nakagawa, N. Sakamoto, N. Enomoto, Y. Tanabe, N. Kanazawa et al., Specific inhibition of hepatitis C virus replication by cyclosporin A, Biochemical and Biophysical Research Communications, vol.313, issue.1, pp.313-355, 2004.
DOI : 10.1016/j.bbrc.2003.11.080

K. Nakai, T. Okamoto, T. Kimura-someya, K. Ishii, C. K. Lim et al., Oligomerization of Hepatitis C Virus Core Protein Is Crucial for Interaction with the Cytoplasmic Domain of E1 Envelope Protein, Journal of Virology, vol.80, issue.22, pp.80-11265, 2006.
DOI : 10.1128/JVI.01203-06

J. Neyts, Selective inhibitors of hepatitis C virus replication, Antiviral Research, vol.71, issue.2-3, pp.363-371, 2006.
DOI : 10.1016/j.antiviral.2006.06.006

A. Owsianka, R. F. Clayton, L. D. Loomis-price, J. A. Mckeating, and A. H. Patel, Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles £ To the best of their knowledge, authors have no real or perceived conflicts of interests. reveals structural dissimilarities between different forms of E2, J Gen Virol, pp.82-1877, 2001.

A. Owsianka, A. W. Tarr, V. S. Juttla, D. Lavillette, B. Bartosch et al., Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein, Journal of Virology, vol.79, issue.17, pp.79-11095, 2005.
DOI : 10.1128/JVI.79.17.11095-11104.2005

K. Y. Paek, C. S. Kim, S. M. Park, J. H. Kim, and S. K. Jang, RNA-Binding Protein hnRNP D Modulates Internal Ribosome Entry Site-Dependent Translation of Hepatitis C Virus RNA, Journal of Virology, vol.82, issue.24, pp.82-12082, 2008.
DOI : 10.1128/JVI.01405-08

J. Paeshuyse, I. Vliegen, L. Coelmont, P. Leyssen, O. Tabarrini et al., Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors, Antimicrobial Agents and Chemotherapy, vol.52, issue.9, pp.52-3433, 2008.
DOI : 10.1128/AAC.01534-07

F. Pauwels, W. Mostmans, L. M. Quirynen, L. Van-der-helm, C. W. Boutton et al., Binding-Site Identification and Genotypic Profiling of Hepatitis C Virus Polymerase Inhibitors, Journal of Virology, vol.81, issue.13, pp.81-6909, 2007.
DOI : 10.1128/JVI.01543-06

J. M. Pawlotsky, Pathophysiology of hepatitis C virus infection and related liver disease, Trends in Microbiology, vol.12, issue.2, pp.96-102, 2004.
DOI : 10.1016/j.tim.2003.12.005

J. M. Pawlotsky, Hepatitis C Virus Population Dynamics During Infection, Curr Top Microbiol Immunol, vol.299, pp.261-284, 2006.
DOI : 10.1007/3-540-26397-7_9

I. M. Pedersen, G. Cheng, S. Wieland, S. Volinia, C. M. Croce et al., Interferon modulation of cellular microRNAs as an antiviral mechanism, Nature, vol.102, issue.7164, pp.449-919, 2007.
DOI : 10.1038/nature06205

L. Pichard, E. Raulet, G. Fabre, J. B. Ferrini, J. C. Ourlin et al., Human Hepatocyte Culture, Methods Mol Biol, vol.320, pp.283-293, 2006.
DOI : 10.1385/1-59259-998-2:283

L. Pichard-garcia, S. Gerbal-chaloin, J. B. Ferrini, J. M. Fabre, and P. Maurel, Use of long-term cultures of human hepatocytes to study cytochrome P450 gene expression, Methods Enzymol, vol.357, pp.311-321, 2002.
DOI : 10.1016/S0076-6879(02)57689-8

T. Pietschmann and R. Bartenschlager, Tissue culture and animal models for hepatitis C virus, Clinics in Liver Disease, vol.7, issue.1, pp.23-43, 2003.
DOI : 10.1016/S1089-3261(02)00071-5

T. Pietschmann, A. Kaul, G. Koutsoudakis, A. Shavinskaya, S. Kallis et al., Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras, Proceedings of the National Academy of Sciences, vol.103, issue.19, pp.7408-7413, 2006.
DOI : 10.1073/pnas.0504877103

P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi et al., Binding of Hepatitis C Virus to CD81, Science, vol.282, issue.5390, pp.282-938, 1998.
DOI : 10.1126/science.282.5390.938

A. Ploss, M. J. Evans, V. A. Gaysinskaya, M. Panis, H. You et al., Human occludin is a hepatitis C virus entry factor required for infection of mouse cells, Nature, vol.309, issue.7231, 2009.
DOI : 10.1038/nature07684

S. Pollard, Calcineurin inhibition and disease recurrence in the hepatitis C virus-positive liver transplant recipient, Liver International, vol.72, issue.1, pp.402-406, 2004.
DOI : 10.1097/01.TP.0000129095.51031.42

S. Preiss, A. Thompson, X. Chen, S. Rodgers, V. Markovska et al., Characterization of the innate immune signalling pathways in hepatocyte cell lines, Journal of Viral Hepatitis, vol.127, issue.5, pp.15-888, 2008.
DOI : 10.1111/j.1365-2893.2008.01001.x

A. M. Prince, T. Huima-byron, T. S. Parker, and D. M. Levine, Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins, Journal of Viral Hepatitis, vol.68, issue.1, pp.11-17, 1996.
DOI : 10.1126/science.1279801

G. Randall, M. Panis, J. D. Cooper, T. L. Tellinghuisen, K. E. Sukhodolets et al., Cellular cofactors affecting hepatitis C virus infection and replication, Proceedings of the National Academy of Sciences, vol.104, issue.31, pp.104-12884, 2007.
DOI : 10.1073/pnas.0704894104
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1937561

R. E. Randall and S. Goodbourn, Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures, Journal of General Virology, vol.89, issue.1, pp.1-47, 2008.
DOI : 10.1099/vir.0.83391-0

R. B. Ray, K. Meyer, and R. Ray, Hepatitis C Virus Core Protein Promotes Immortalization of Primary Human Hepatocytes, Virology, vol.271, issue.1, pp.197-204, 2000.
DOI : 10.1006/viro.2000.0295

M. Regeard, M. Trotard, C. Lepere, P. Gripon, and J. Le-seyec, Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor, Journal of Viral Hepatitis, vol.79, issue.9, pp.15-865, 2008.
DOI : 10.1111/j.1365-2893.2008.01048.x
URL : https://hal.archives-ouvertes.fr/hal-00675913

M. Reiser, H. Hinrichsen, Y. Benhamou, H. W. Reesink, H. Wedemeyer et al., Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C, Hepatology, vol.78, issue.4, pp.41-832, 2005.
DOI : 10.1002/hep.20612

G. M. Reynolds, H. J. Harris, A. Jennings, K. Hu, J. Grove et al., Hepatitis C virus receptor expression in normal and diseased liver tissue, Hepatology, vol.139, issue.2, pp.47-418, 2008.
DOI : 10.1002/hep.22028

V. Rocha-perugini, C. Montpellier, D. Delgrange, C. Wychowski, F. Helle et al., The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry, PLoS ONE, vol.100, issue.4, p.1866, 2008.
DOI : 10.1371/journal.pone.0001866.t002

T. Roskams, Liver stem cells and their implication in hepatocellular and cholangiocarcinoma, Oncogene, vol.40, issue.27, pp.3818-3822, 2006.
DOI : 10.1002/hep.20082

K. B. Rothwangl, B. Manicassamy, S. L. Uprichard, and L. Rong, Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding, Virology Journal, vol.5, issue.1, p.46, 2008.
DOI : 10.1186/1743-422X-5-46

S. Rumin, P. Berthillon, E. Tanaka, K. Kiyosawa, M. A. Trabaud et al., Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro, Journal of General Virology, vol.80, issue.11, pp.80-3007, 1999.
DOI : 10.1099/0022-1317-80-11-3007

K. J. Ryu and S. W. Lee, Comparative analysis of intracellular trans-splicing ribozyme activity against hepatitis C virus internal ribosome entry site, J Microbiol, vol.42, issue.4, pp.361-364, 2004.

S. K. Saha, E. M. Pietras, J. Q. He, J. R. Kang, S. Y. Liu et al., Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif, The EMBO Journal, vol.5, issue.14, pp.25-3257, 2006.
DOI : 10.1038/sj.emboj.7601220

K. Saito, K. Meyer, R. Warner, A. Basu, R. B. Ray et al., Hepatitis C Virus Core Protein Inhibits Tumor Necrosis Factor Alpha-Mediated Apoptosis by a Protective Effect Involving Cellular FLICE Inhibitory Protein, Journal of Virology, vol.80, issue.9, pp.4372-4379, 2006.
DOI : 10.1128/JVI.80.9.4372-4379.2006

T. Saito, R. Hirai, Y. M. Loo, D. Owen, C. L. Johnson et al., Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2, Proceedings of the National Academy of Sciences, vol.104, issue.2, pp.582-587, 2007.
DOI : 10.1073/pnas.0606699104

T. Saito, D. M. Owen, F. Jiang, J. Marcotrigiano, M. Gale et al., Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA, Nature, vol.448, issue.7203, pp.454-523, 2008.
DOI : 10.1038/nature07106

H. Sakamoto, K. Okamoto, M. Aoki, H. Kato, A. Katsume et al., Host sphingolipid biosynthesis as a target for hepatitis C virus therapy, Nature Chemical Biology, vol.228, issue.6, pp.333-337, 2005.
DOI : 10.1128/JVI.78.7.3480-3488.2004

M. Sato, H. Suemori, N. Hata, M. Asagiri, K. Ogasawara et al., Distinct and Essential Roles of Transcription Factors IRF-3 and IRF-7 in Response to Viruses for IFN-??/?? Gene Induction, Immunity, vol.13, issue.4, pp.539-548, 2000.
DOI : 10.1016/S1074-7613(00)00053-4

E. Scarselli, H. Ansuini, R. Cerino, R. M. Roccasecca, S. Acali et al., The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus, The EMBO Journal, vol.269, issue.19, pp.5017-5025, 2002.
DOI : 10.1093/emboj/cdf529

S. Sharma, B. R. Tenoever, N. Grandvaux, G. P. Zhou, R. Lin et al., Triggering the Interferon Antiviral Response Through an IKK-Related Pathway, Science, vol.300, issue.5622, pp.300-1148, 2003.
DOI : 10.1126/science.1081315

M. Y. Sheikh, J. Choi, I. Qadri, J. E. Friedman, and A. J. Sanyal, Hepatitis C virus infection: Molecular pathways to metabolic syndrome, Hepatology, vol.14, issue.6, pp.47-2127, 2008.
DOI : 10.1002/hep.22269

J. Shepherd, J. Jones, D. Hartwell, P. Davidson, A. Price et al., Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation, Health Technol Assess, issue.11, pp.11-12, 2007.

S. T. Shi, K. J. Lee, H. Aizaki, S. B. Hwang, and M. M. Lai, Hepatitis C Virus RNA Replication Occurs on a Detergent-Resistant Membrane That Cofractionates with Caveolin-2, Journal of Virology, vol.77, issue.7, 2003.
DOI : 10.1128/JVI.77.7.4160-4168.2003

V. Soriano, A. Madejon, E. Vispo, P. Labarga, J. Garcia-samaniego et al., Emerging drugs for hepatitis C, Expert Opinion on Emerging Drugs, vol.44, issue.1, pp.1-19, 2008.
DOI : 10.1097/QAD.0b013e3281084e4d

R. E. Stauber and H. H. Kessler, Drugs in Development for Hepatitis C, Drugs, vol.42, issue.3, pp.68-1347, 2008.
DOI : 10.2165/00003495-200868100-00002

D. Steinmann, H. Barth, B. Gissler, P. Schurmann, M. I. Adah et al., Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C, Journal of Virology, vol.78, issue.17, pp.78-9030, 2004.
DOI : 10.1128/JVI.78.17.9030-9040.2004

A. Street, A. Macdonald, C. Mccormick, and M. Harris, Hepatitis C virus NS5A- mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription, J Virol, issue.8, pp.79-5006, 2005.

R. Sumpter, . Jr, Y. M. Loo, E. Foy, K. Li et al., Regulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication through a Cellular RNA Helicase, RIG-I, Journal of Virology, vol.79, issue.5, pp.79-2689, 2005.
DOI : 10.1128/JVI.79.5.2689-2699.2005

L. Supekova, F. Supek, J. Lee, S. Chen, N. Gray et al., Identification of Human Kinases Involved in Hepatitis C Virus Replication by Small Interference RNA Library Screening, Journal of Biological Chemistry, vol.283, issue.1, pp.29-36, 2008.
DOI : 10.1074/jbc.M703988200

T. Suzuki, K. Ishii, H. Aizaki, and T. Wakita, Hepatitis C viral life cycle, Advanced Drug Delivery Reviews, vol.59, issue.12, pp.1200-1212, 2007.
DOI : 10.1016/j.addr.2007.04.014

T. Taguchi, M. Nagano-fujii, M. Akutsu, H. Kadoya, S. Ohgimoto et al., Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining regionindependent manner, J Gen Virol, pp.85-959, 2004.

M. Tanaka, M. Nagano-fujii, L. Deng, S. Ishido, K. Sada et al., Singlepoint mutations of hepatitis C virus NS3 that impair p53 interaction and anti-apoptotic activity of NS3, Biochem Biophys Res Commun, issue.3, pp.340-792, 2006.

Y. Tanaka, T. Shimoike, K. Ishii, R. Suzuki, T. Suzuki et al., Selective Binding of Hepatitis C Virus Core Protein to Synthetic Oligonucleotides Corresponding to the 5??? Untranslated Region of the Viral Genome, Virology, vol.270, issue.1, pp.229-236, 2000.
DOI : 10.1006/viro.2000.0252

Y. Tanji, M. Hijikata, Y. Hirowatari, and K. Shimotohno, Hepatitis C virus polyprotein processing: kinetics and mutagenic analysis of serine proteinasedependent cleavage, J Virol, issue.12, pp.68-8418, 1994.

D. R. Taylor, S. T. Shi, P. R. Romano, G. N. Barber, and M. M. Lai, Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein, Science, vol.285, issue.5424, pp.285-107, 1999.
DOI : 10.1126/science.285.5424.107

B. R. Tenoever, S. Sharma, W. Zou, Q. Sun, N. Grandvaux et al., Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity, J Virol, issue.19, pp.78-10636, 2004.

A. Thompson, K. Patel, H. Tillman, and J. G. Mchutchison, Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges, Journal of Hepatology, vol.50, issue.1, pp.184-194, 2009.
DOI : 10.1016/j.jhep.2008.10.011

R. Thomssen, S. Bonk, and A. Thiele, Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins, Med Microbiol Immunol (Berl), issue.6, pp.182-329, 1993.

A. Trahtenherts, M. Gal-tanamy, R. Zemel, L. Bachmatov, S. Loewenstein et al., Inhibition of hepatitis C virus RNA replicons by peptide aptamers, Antiviral Research, vol.77, issue.3, pp.77-195, 2008.
DOI : 10.1016/j.antiviral.2007.12.013

J. B. Trepanier, J. E. Tanner, and C. Alfieri, Reduction in intracellular HCV RNA and virus protein expression in human hepatoma cells following treatment with 2???-O-methyl-modified anti-core deoxyribozyme, Virology, vol.377, issue.2, pp.339-344, 2008.
DOI : 10.1016/j.virol.2008.04.022

M. Triyatni, B. Saunier, P. Maruvada, A. R. Davis, L. Ulianich et al., Interaction of Hepatitis C Virus-Like Particles and Cells: a Model System for Studying Viral Binding and Entry, Journal of Virology, vol.76, issue.18, pp.76-9335, 2002.
DOI : 10.1128/JVI.76.18.9335-9344.2002

D. M. Tscherne, C. T. Jones, M. J. Evans, B. D. Lindenbach, J. A. Mckeating et al., Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry, Journal of Virology, vol.80, issue.4, pp.1734-1741, 2006.
DOI : 10.1128/JVI.80.4.1734-1741.2006

N. Usman and L. M. Blatt, Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics, Journal of Clinical Investigation, vol.106, issue.10, pp.1197-1202, 2000.
DOI : 10.1172/JCI11631

D. Vitour and E. F. Meurs, Regulation of Interferon Production by RIG-I and LGP2: A Lesson in Self-Control, Science's STKE, vol.2007, issue.384, pp.2007-2027, 2007.
DOI : 10.1126/stke.3842007pe20

O. Voinnet, Induction and suppression of RNA silencing: insights from viral infections, Nature Reviews Genetics, vol.77, issue.3, pp.206-220, 2005.
DOI : 10.1038/nrg1555

C. Voisset, N. Callens, E. Blanchard, A. Op-de-beeck, J. Dubuisson et al., High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I, Journal of Biological Chemistry, vol.280, issue.9, pp.7793-7799, 2005.
DOI : 10.1074/jbc.M411600200
URL : https://hal.archives-ouvertes.fr/hal-00105456

C. Voisset, M. Lavie, F. Helle, A. Op-de-beeck, A. Bilheu et al., Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry, Cellular Microbiology, vol.43, issue.3, pp.606-617, 2008.
DOI : 10.1073/pnas.0503596102

C. Voisset, A. Op-de-beeck, P. Horellou, M. Dreux, T. Gustot et al., High-density lipoproteins reduce the neutralizing effect of hepatitis C virus, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00105505

T. Von-hahn, B. D. Lindenbach, A. Boullier, O. Quehenberger, M. Paulson et al., Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells, Hepatology, vol.122, issue.5, pp.43-932, 2006.
DOI : 10.1002/hep.21139

T. Wakita, HCV research and anti-HCV drug discovery: Toward the next generation, Advanced Drug Delivery Reviews, vol.59, issue.12, pp.1196-1199, 2007.
DOI : 10.1016/j.addr.2007.08.021

T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto et al., Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nature Medicine, vol.37, issue.7, pp.11-791, 2005.
DOI : 10.1002/jmv.10297

C. Wang, M. Gale, . Jr, B. C. Keller, H. Huang et al., Identification of FBL2 As a Geranylgeranylated Cellular Protein Required for Hepatitis C Virus RNA Replication, Molecular Cell, vol.18, issue.4, pp.425-434, 2005.
DOI : 10.1016/j.molcel.2005.04.004

C. Wang, P. Sarnow, and A. Siddiqui, Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism, J Virol, vol.67, issue.6, pp.3338-3344, 1993.

Y. Wang, N. Kato, A. Jazag, N. Dharel, M. Otsuka et al., Hepatitis C Virus Core Protein Is a Potent Inhibitor of RNA Silencing-Based Antiviral Response, Gastroenterology, vol.130, issue.3, pp.130-883, 2006.
DOI : 10.1053/j.gastro.2005.12.028

T. Watanabe, T. Umehara, and M. Kohara, Therapeutic application of RNA interference for hepatitis C virus, Advanced Drug Delivery Reviews, vol.59, issue.12, pp.1263-1276, 2007.
DOI : 10.1016/j.addr.2007.03.022

S. Wunschmann, J. D. Medh, D. Klinzmann, W. N. Schmidt, and J. T. Stapleton, Characterization of Hepatitis C Virus (HCV) and HCV E2 Interactions with CD81 and the Low-Density Lipoprotein Receptor, Journal of Virology, vol.74, issue.21, pp.74-10055, 2000.
DOI : 10.1128/JVI.74.21.10055-10062.2000

L. G. Xu, Y. Y. Wang, K. J. Han, L. Y. Li, Z. Zhai et al., VISA Is an Adapter Protein Required for Virus-Triggered IFN-?? Signaling, Molecular Cell, vol.19, issue.6, pp.727-740, 2005.
DOI : 10.1016/j.molcel.2005.08.014

M. Yanagi, M. St-claire, S. U. Emerson, R. H. Purcell, and J. Bukh, In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone, Proceedings of the National Academy of Sciences, vol.96, issue.5, pp.96-2291, 1999.
DOI : 10.1073/pnas.96.5.2291

W. Yang, B. L. Hood, S. L. Chadwick, S. Liu, S. C. Watkins et al., Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production, Hepatology, vol.81, issue.5, pp.48-1396, 2008.
DOI : 10.1002/hep.22508

J. Ye, C. Wang, R. Sumpter, . Jr, M. S. Brown et al., Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation, Proceedings of the National Academy of Sciences, vol.100, issue.26, pp.100-15865, 2003.
DOI : 10.1073/pnas.2237238100

M. Yi, R. A. Villanueva, D. L. Thomas, T. Wakita, and S. M. Lemon, Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells, Proceedings of the National Academy of Sciences, vol.103, issue.7, pp.2310-2315, 2006.
DOI : 10.1073/pnas.0510727103

M. Yoneyama, M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi et al., The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses, Nature Immunology, vol.120, issue.7, pp.730-737, 2004.
DOI : 10.1038/ni910

B. J. Yoo, M. J. Selby, J. Choe, B. S. Suh, S. H. Choi et al., Transfection of a differentiated human hepatoma cell line (Huh7) with in vitro-transcribed hepatitis C virus (HCV) RNA and establishment of a long-term culture persistently infected with HCV, J Virol, vol.69, issue.1, pp.32-38, 1995.

T. Yoshida, T. Hanada, T. Tokuhisa, K. Kosai, M. Sata et al., Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation, The Journal of Experimental Medicine, vol.70, issue.5, pp.641-653, 2002.
DOI : 10.1073/pnas.171311298

Z. Younossi, J. Kallman, and J. Kincaid, The effects of HCV infection and management on health-related quality of life, Hepatology, vol.40, issue.3, pp.806-816, 2007.
DOI : 10.1002/hep.21565

M. B. Zeisel, G. Koutsoudakis, E. K. Schnober, A. Haberstroh, H. E. Blum et al., Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81, Hepatology, vol.279, issue.6, pp.46-1722, 2007.
DOI : 10.1002/hep.21994
URL : https://hal.archives-ouvertes.fr/inserm-00395706

J. Zhang, G. Randall, A. Higginbottom, P. Monk, C. M. Rice et al., CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection, Journal of Virology, vol.78, issue.3, pp.78-1448, 2004.
DOI : 10.1128/JVI.78.3.1448-1455.2004

J. Zhang, O. Yamada, T. Sakamoto, H. Yoshida, T. Iwai et al., Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus, Virology, vol.320, issue.1, pp.135-143, 2004.
DOI : 10.1016/j.virol.2003.11.023

W. Zhao, G. Y. Liao, Y. J. Jiang, and S. D. Jiang, No requirement of HCV 5???NCR for HCV-like particles assembly in insect cells, World Journal of Gastroenterology, vol.9, issue.10, pp.9-2226, 2003.
DOI : 10.3748/wjg.v9.i10.2226

A. Zheng, F. Yuan, Y. Li, F. Zhu, P. Hou et al., Claudin-6 and Claudin-9 Function as Additional Coreceptors for Hepatitis C Virus, Journal of Virology, vol.81, issue.22, pp.81-12465, 2007.
DOI : 10.1128/JVI.01457-07

J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato et al., Robust hepatitis C virus infection in vitro, Proceedings of the National Academy of Sciences, vol.102, issue.26, pp.102-9294, 2005.
DOI : 10.1073/pnas.0503596102

S. Zhou, R. Liu, B. M. Baroudy, B. A. Malcolm, and G. R. Reyes, The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA, Virology, vol.310, issue.2, pp.310-333, 2003.
DOI : 10.1016/S0042-6822(03)00152-1

H. Zhu, D. R. Nelson, J. M. Crawford, and C. Liu, Defective Jak-Stat Activation in Hepatoma Cells Is Associated with Hepatitis C Viral IFN-?? Resistance, Journal of Interferon & Cytokine Research, vol.25, issue.9, pp.528-539, 2005.
DOI : 10.1089/jir.2005.25.528